Vijay Pande, founding partner of a16z bio and health strategy, steps down
Since its inception in 2014, a16z Bio+ Health has successfully raised four substantial funds, each nearly $3 billion, with the latest $1.5 billion fund closing in 2022.
MAIN POINTS
- a16z Bio+ Health was founded in 2014.
- The firm has raised four funds since its inception.
- Each fund is nearly $3 billion in size.
- The most recent fund, closed in 2022, was $1.5 billion.
TAKEAWAYS
- a16z Bio+ Health has demonstrated consistent fundraising success.
- The firm's financial growth is marked by substantial fund sizes.
- Recent fundraising efforts culminated in a significant $1.5 billion fund.
- The firm's strategic growth reflects its strong position in the market.